Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii.
Wisplinghoff
Hilmar
H
Decker
Mathias
M
Haefs
Christiane
C
Krut
Oleg
O
Plum
Georg
G
Seifert
Harald
H
D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000453:epidemiology* / Q000382:microbiology; D040981:Acinetobacter baumannii / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D000890:Anti-Infective Agents / Q000494:pharmacology*; D027081:DNA Gyrase / Q000235:genetics*; D027101:DNA Topoisomerase IV / Q000235:genetics*; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics*; D005060:Europe / Q000453:epidemiology; D024841:Fluoroquinolones; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000706:statistics & numerical data; D009154:Mutation / Q000502:physiology; D014481:United States / Q000453:epidemiology
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase